Ruonan Yin

Ruonan Yin

UNVERIFIED PROFILE

Are you Ruonan Yin?   Register this Author

Register author
Ruonan Yin

Ruonan Yin

Publications by authors named "Ruonan Yin"

Are you Ruonan Yin?   Register this Author

4Publications

68Reads

-Profile Views

Adipocyte OGT governs diet-induced hyperphagia and obesity.

Nat Commun 2018 11 30;9(1):5103. Epub 2018 Nov 30.

Program in Integrative Cell Signaling and Neurobiology of Metabolism and Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-07461-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269424PMC
November 2018

O-GlcNAc: A Bittersweet Switch in Liver.

Front Endocrinol (Lausanne) 2014 17;5:221. Epub 2014 Dec 17.

Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine , New Haven, CT , USA ; Section of Comparative Medicine, Yale University School of Medicine , New Haven, CT , USA ; Department of Cellular and Molecular Physiology, Yale University School of Medicine , New Haven, CT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fendo.2014.00221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269194PMC
January 2015

O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat.

Cell 2014 Oct;159(2):306-17

Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA; Section of Comparative Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA; Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2014.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509746PMC
October 2014

Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.

Cell Rep 2014 May 9;7(4):999-1008. Epub 2014 May 9.

Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06510, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074596PMC
May 2014